新世界(600628.SH)上半年淨利潤預增31166.02%左右
格隆匯7月19日丨新世界(600628.SH)公佈,公司2021年上半年歸屬於上市公司股東的淨利潤與上年同期相比,預計增加6080.49萬元左右,同比增加31166.02%左右。
公司2021年上半年歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比,預計增加6736.6萬元左右。
公司2020年上半年受疫情影響較大,今年上半年,公司進一步推動新世界城的場景經濟、體驗經濟,加快商旅文體融合發展,聚人流、變商流、轉財流,以提質增效為主線,以擴銷增盈為重點,收入與利潤同比增加較多。
公司報吿期內醫藥銷售業經營正常,且穩中有升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.